Abiomed Stock
StockStockISIN: US0036541003
Ticker: ABMD-RM
US0036541003
ABMD-RM
Price
Frequently asked questions
What is Abiomed's market capitalization?
The market capitalization of Abiomed is $17.18B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Abiomed's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Abiomed is 65.49. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Abiomed?
Abiomed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 5.818. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Abiomed's stock?
Currently, 7 analysts cover Abiomed's stock, with a consensus target price of $368.00. Analyst ratings provide insights into the stock's expected performance.
What is Abiomed's revenue over the trailing twelve months?
Over the trailing twelve months, Abiomed reported a revenue of $1.07B.
What is the EBITDA for Abiomed?
Abiomed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $260.67M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Abiomed?
Abiomed has a free cash flow of $217.22M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Abiomed's stock?
The 5-year beta for Abiomed is 1.38. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Abiomed have, and what sector and industry does it belong to?
Abiomed employs approximately 2,003 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.
What is the free float of Abiomed's shares?
The free float of Abiomed is 44.18M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$17.18B5Y beta
1.38EPS (TTM)
5.818Free Float
44.18MP/E ratio (TTM)
65.49Revenue (TTM)
$1.07BEBITDA (TTM)
$260.67MFree Cashflow (TTM)
$217.22MAnalyst Ratings
The price target is $368.00 and the stock is covered by 7 analysts.
Buy
1
Hold
6
Sell
0
Information
ABIOMED Inc is a United States-based company. The Company is a provider of medical technology that provides circulatory support and oxygenation. Its products include Impella heart pumps, Abiomed breethe OXY-1 system and services and support. The Company’s products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure.
2,003
Medical Equipment & Supplies
Health Care
Identifier
ISIN
US0036541003
Primary Ticker
ABMD-RM